Sandoz files appeal in patent infringement lawsuit

Sandoz has filed an appeal of a recent court judgment that upheld the patents protecting AzaSite, according to a press release from InSite Vision.The appeal was filed in the United States Court of Appeals for the Federal Circuit.In 2011, Sandoz filed an abbreviated new drug application with the U.S. Food and Drug Administration to market a generic version of AzaSite (azithromycin 1% ophthalmic solution, InSite) before expiration of the patents that cover AzaSite and its use, the release said.

Full Story →